A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting-Reference-Cited by-同舟云学术

A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting

Published:2010-08-18 Issue:5 Volume:150 Page:574-586
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Kügler Markus,Stein Christoph,Kellner Christian,Mentz Kristin,Saul Domenica,Schwenkert Michael,Schubert Ingo,Singer Heiko,Oduncu Fuat,Stockmeyer Bernhard,Mackensen Andreas,Fey Georg H.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08300.x/fullpdf

Reference69 articles.

1. Tumor regression in cancer patients by very low doses of a T cell-engaging antibody;Bargou;Science,2008

2. Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay;Benedict;Journal of Immunological Methods,1997

3. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell;Bonnet;Nature Medicine,1997

4. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia;Bross;Clinical Cancer Research,2001

5. A recombinant bispecific single-chain Fv antibody against HLA class II and FcgammaRIII (CD16) triggers effective lysis of lymphoma cells;Bruenke;British Journal of Haematology,2004

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor T-cell therapy in acute myeloid leukaemia: Novel therapeutic approaches to longstanding challenges;Gene Reports;2024-09

2. Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies;Experimental Hematology & Oncology;2024-02-23

3. Better safe than sorry: dual targeting antibodies for cancer immunotherapy;Biological Chemistry;2024-02-01

4. Epitope editing enables targeted immunotherapy of acute myeloid leukaemia;Nature;2023-08-30

5. NK cell defects: implication in acute myeloid leukemia;Frontiers in Immunology;2023-05-09